Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Sell
37
SEM Quote, Financials, Valuation and Earnings
Last price:
$19.08
Seasonality move
:
-1.96%
Day range:
$18.86 - $19.13
52-week range:
$18.02 - $40.98
Dividend yield:
2.61%
P/E ratio:
8.94x
P/S ratio:
0.34x
P/B ratio:
1.29x
Volume:
361.9K
Avg. volume:
1.4M
1-year change:
-21.02%
Market cap:
$2.5B
Revenue:
$6.7B
EPS (TTM):
$2.14
Analysts' Opinion
-
Consensus RatingSelect Medical Holdings has received a consensus rating of Buy. The company's average rating is a Buy based on 3 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $41.40, Select Medical Holdings has an estimated upside of 79.04% from its current price of $19.13.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $37.00 representing 100% downside risk from its current price of $19.13.
Fair Value
-
According to the consensus of 4 analysts, Select Medical Holdings has 79.04% upside to fair value with a price target of $41.40 per share.
SEM vs. S&P 500
-
Over the past 5 trading days, Select Medical Holdings has underperformed the S&P 500 by -2.81% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Select Medical Holdings does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Select Medical Holdings has grown year-over-year revenues for 17 quarters straight. In the most recent quarter Select Medical Holdings reported revenues of $1.8B.
Earnings Growth
-
Select Medical Holdings has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Select Medical Holdings reported earnings per share of $0.43.
Enterprise value:
5.8B
EV / Invested capital:
1.07x
Price / LTM sales:
0.34x
EV / EBIT:
8.87x
EV / Revenue:
0.83x
PEG ratio (5yr expected):
0.43x
EV / Free cash flow:
16.50x
Price / Operating cash flow:
6.73x
Enterprise value / EBITDA:
6.70x
Gross Profit (TTM):
$1B
Return On Assets:
3.53%
Net Income Margin (TTM):
3.97%
Return On Equity:
15.65%
Return On Invested Capital:
5.13%
Operating Margin:
8.01%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $6.3B | $6.6B | $7B | $1.7B | $1.8B | |
| Gross Profit | $717.9M | $892.9M | $1B | $223.2M | $237.3M | |
| Operating Income | $394M | $527.5M | $607.2M | $130M | $141.1M | |
| EBITDA | $633.1M | $757.2M | $868.3M | $179.2M | $213.4M | |
| Diluted EPS | $1.38 | $1.77 | $2.14 | $0.38 | $0.43 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.6B | $1.8B | $1.2B | $1.3B | $1.4B | |
| Total Assets | $7.7B | $7.9B | $7.6B | $7.7B | $8B | |
| Current Liabilities | $1.3B | $1.3B | $1.2B | $1.2B | $1.2B | |
| Total Liabilities | $6.4B | $6.5B | $6.2B | $6.1B | $5.7B | |
| Total Equity | $1.2B | $1.4B | $1.4B | $1.6B | $2.3B | |
| Total Debt | $3.4B | $3.4B | $3.8B | $3.8B | $3.2B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $211.5M | $415.2M | $571.9M | $116.3M | $181M | |
| Cash From Investing | -$268.4M | -$256.1M | -$226.4M | -$63M | -$45.1M | |
| Cash From Financing | -$582.9M | -$189.8M | -$231.4M | -$77M | -$55.6M | |
| Free Cash Flow | $21.3M | $191.3M | $352.5M | $66.1M | $130.3M | |
SEM
Sector
Market Cap
$2.5B
$45.6M
Price % of 52-Week High
46.68%
45.55%
Dividend Yield
2.61%
0%
Shareholder Yield
--
-0.74%
1-Year Price Total Return
-21.02%
-31.35%
Beta (5-Year)
1.278
0.772
Dividend yield:
2.61%
Annualized payout:
$0.50
Payout ratio:
23.35%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$19.00
200-day SMA
Sell
Level
$32.25
Bollinger Bands (100)
Sell
Level
25.54 - 38.1
Chaikin Money Flow
Buy
Level
83M
20-day SMA
Sell
Level
$19.83
Relative Strength Index (RSI14)
Sell
Level
26.89
ADX Line
Buy
Level
23.07
Williams %R
Neutral
Level
-59.7826
50-day SMA
Sell
Level
$29.47
MACD (12, 26)
Sell
Level
-3.34
25-day Aroon Oscillator
Sell
Level
-72
On Balance Volume
Neutral
Level
104.2M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.5502)
Sell
CA Score
(Annual)
Level (-1.3581)
Buy
Beneish M-Score
(Annual)
Level (-2.7381)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (1.2642)
Buy
Piotroski F Score
(Annual)
Level (8)
Sell
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Select Medical Holdings Corp is a healthcare company that operates through four main segments: critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and Concentra institutions. Critical illness recovery hospitals and rehabilitation centres are designed for patients requiring extended recovery time with medical services. These two sectors combined compose roughly half of the total revenue and include over 103 critical illness recovery hospitals and inpatient rehab facilities. The outpatient rehabilitation segment includes over 1,928 rehabilitation clinics. The Concentra segment includes over 540 occupational health centers and 147 onsite clinics. The company is headquartered in Pennsylvania, and it operates across the United States.
Stock Forecast FAQ
In the current month, SEM has received 3 Buy ratings 1 Hold ratings, and 0 Sell ratings. The SEM average analyst price target in the past 3 months is $41.40.
-
Where Will Select Medical Holdings Stock Be In 1 Year?
According to analysts, the consensus estimate is that Select Medical Holdings share price will rise to $41.40 per share over the next 12 months.
-
What Do Analysts Say About Select Medical Holdings?
Analysts are divided on their view about Select Medical Holdings share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Select Medical Holdings is a Sell and believe this share price will drop from its current level to $37.00.
-
What Is Select Medical Holdings's Price Target?
The price target for Select Medical Holdings over the next 1-year time period is forecast to be $41.40 according to 4 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is SEM A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Select Medical Holdings is a Buy. 3 of 4 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of SEM?
You can purchase shares of Select Medical Holdings via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Select Medical Holdings shares.
-
What Is The Select Medical Holdings Share Price Today?
Select Medical Holdings was last trading at $19.08 per share. This represents the most recent stock quote for Select Medical Holdings. Yesterday, Select Medical Holdings closed at $19.13 per share.
-
How To Buy Select Medical Holdings Stock Online?
In order to purchase Select Medical Holdings stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
87
PSIX alert for Dec 25
Power Solutions International [PSIX] is up 27.42% over the past day.
Buy
65
TSLL alert for Dec 25
Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.
Buy
75
SMLR alert for Dec 25
Semler Scientific [SMLR] is up 15.37% over the past day.
